The Justice Department charged in a criminal information in the Western District of Virginia that McKinsey's US entity conspired with Purdue Pharma and others to aid and abet the misbranding of prescription drugs, and knowingly destroyed records to impede a federal investigation. State attorneys general and local governments alleged in civil suits that McKinsey's advice to opioid makers, including on boosting OxyContin sales, contributed to the opioid crisis.
4 February 2021 to today · 6 dated events · 7 sources
Where it stands now · as of 30 October 2026
As of 30 October 2026 McKinsey is within the term of its 2024 deferred prosecution agreement and Elling's sentence has been imposed.
Overview · 4 Feb 2021 to 22 May 2025 · click a dot to jump
2021
4 Feb 2021
Settlement
$573 million settlement with 47 states, the District of Columbia and five territories
Multistate settlement with McKinsey & Company. McKinsey agreed to pay $573 million, to publish internal documents on its opioid work, to adopt document retention rules, to investigate alleged document destruction by two partners and to stop advising on Schedule II and III narcotics.
McKinsey announces a $230 million settlement with local governments and school districts
Proposed settlement, In re McKinsey & Co. Inc. National Prescription Opiate Consultant Litigation. McKinsey agreed to pay $230 million. Its statement said the settlement contains no admission of liability or wrongdoing. Judge Charles Breyer later granted final approval.
Justice Department announces the DPA and $650 million resolution
Deferred prosecution agreement and civil settlement with McKinsey & Company, Inc. United States. Five-year DPA on a criminal information filed in the US District Court for the Western District of Virginia charging one felony count of knowingly destroying records and one misdemeanor count of conspiring with Purdue and others to aid and abet misbranding. $650 million total, including a criminal penalty of more than $231 million, forfeiture of more than $93 million, $2 million to the Virginia Medicaid Fraud Control Unit and more than $323 million to resolve False Claims Act liability. McKinsey agreed to a 71-page statement of facts, compliance measures, no work on the marketing, sale, promotion or distribution of controlled substances during the five-year term, and a five-year Corporate Integrity Agreement with HHS-OIG. The Justice Department states that McKinsey US admitted it did not inform the FDA that its consultants worked on the Purdue projects, credits it with stopping opioid-specific work in 2019, and describes the details in the charging documents and civil resolution as merely allegations.
Guilty plea, United States v. Martin Elling. Elling pleaded guilty to a one-count information charging him with knowingly destroying records to impede a Justice Department investigation.
Last updated 30 October 2026. Spotted an error? See corrections. Every event links to the record it comes from. Allegations are attributed to whoever made them.